MARKET

IMRN

IMRN

Immuron Ltd
NASDAQ
0.8058
+0.0258
+3.31%
After Hours: 0.8058 0 0.00% 16:04 02/06 EST
OPEN
0.8390
PREV CLOSE
0.7800
HIGH
0.8400
LOW
0.7960
VOLUME
25.84K
TURNOVER
--
52 WEEK HIGH
2.390
52 WEEK LOW
0.6765
MARKET CAP
6.58M
P/E (TTM)
-1.3566
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMRN last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at IMRN last week (0119-0123)?
Weekly Report · 01/26 10:12
Immuron Limited Publishes Transcript of CEO Presentation at Emerging Growth Conference
Reuters · 01/26 06:51
Emerging Growth Research Maintains Buy-Extended Rating on Immuron Limited With $3.50 Price Target
Reuters · 01/22 11:00
Immuron Reports Continued Travelan Sales Growth and ProIBS Launch in H1 FY26
TipRanks · 01/20 12:27
Reported Monday, Immuron Reports Continued Sales Growth With H1 Global Sales Of AUD$4.2M, Up 5%, Driven By Travelan And ProIBS Launch
Benzinga · 01/20 08:29
BRIEF-Immuron Reports H1 Global Travelan Sales AUD$4.2 Mln
Reuters · 01/19 14:25
Immuron Limited Reports 5% Increase in Global H1 Sales
Reuters · 01/19 11:00
More
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.

Webull offers Immuron Ltd - ADR stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.